Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma

被引：23

作者：

Girgis, Suzette ^{[1
,3
]}

Lin, Shun Xin Wang ^{[1
]}

Pillarisetti, Kodandaram ^{[1
]}

Verona, Raluca ^{[1
]}

Vieyra, Diego ^{[1
]}

Casneuf, Tineke ^{[2
]}

Fink, Damien ^{[1
]}

Miao, Xin ^{[1
]}

Chen, Yang ^{[1
]}

Stephenson, Tara ^{[1
]}

Banerjee, Arnob ^{[1
]}

Hilder, Brandi W. ^{[1
]}

Russell, Jeffery ^{[1
]}

Infante, Jeffrey ^{[1
]}

Elsayed, Yusri ^{[1
]}

Smit, Jennifer ^{[1
]}

Goldberg, Jenna D. ^{[1
]}

机构：

[1] Janssen Res & Dev LLC, Spring House, PA USA

[2] Janssen Res & Dev LLC, Beerse, Belgium

[3] Janssen Res & Dev, 920 Route 202, Raritan, NJ 08869 USA

来源：

BLOOD ADVANCES | 2023年 / 7卷 / 04期

关键词：

CELL MATURATION ANTIGEN; BONE-MARROW; SURVIVAL;

D O I：

10.1182/bloodadvances.2022007625

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：644 / 648

页数：5

共 50 条

[1] Teclistamab in Relapsed or Refractory Multiple Myeloma
Moreau, Philippe
Garfall, Alfred L.
van de Donk, Niels W. C. J.
Nahi, Hareth
San-Miguel, Jesus F.
Oriol, Albert
Nooka, Ajay K.
Martin, Thomas
Rosinol, Laura
Chari, Ajai
Karlin, Lionel
Benboubker, Lotfi
Mateos, Maria-Victoria
Bahlis, Nizar
Popat, Rakesh
Besemer, Britta
Martinez-Lopez, Joaquin
Sidana, Surbhi
Delforge, Michel
Pei, Lixia
Trancucci, Danielle
Verona, Raluca
Girgis, Suzette
Lin, Shun X. W.
Olyslager, Yunsi
Jaffe, Mindy
Uhlar, Clarissa
Stephenson, Tara
Van Rampelbergh, Rian
Banerjee, Arnob
Goldberg, Jenna D.
Kobos, Rachel
Krishnan, Amrita
Usmani, Saad Z.
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
[2] Overview of anti-BCMA CAR-T immunotherapy for multiple myeloma and relapsed/refractory multiple myeloma
Feng, Deming
Sun, Jian
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (02)
[3] Population pharmacokinetics of belantamab mafodotin, a BCMA-targeting agent in patients with relapsed/refractory multiple myeloma
Rathi, Chetan
Collins, Jon
Struemper, Herbert
Opalinska, Joanna
Jewell, Roxanne C.
Ferron-Brady, Geraldine
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 851 - 863
[4] Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
Cohen, Adam D.
Garfall, Alfred L.
Dogan, Ahmet
Lacey, Simon F.
Martin, Chris
Lendvai, Nikoletta
Vogl, Dan T.
Spear, Matthew
Lesokhin, Alexander M.
BLOOD ADVANCES, 2019, 3 (16) : 2487 - 2490
[5] Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
Kambhampati, Swetha
Sheng, Ying
Huang, Chiung-Yu
Bylsma, Sophia
Lo, Mimi
Kennedy, Vanessa
Natsuhara, Kelsey
Martin, Thomas
Wolf, Jeffrey
Shah, Nina
Wong, Sandy W.
BLOOD ADVANCES, 2022, 6 (07) : 2045 - 2054
[6] Gemcitabine in Treating Patients with Refractory or Relapsed Multiple Myeloma
Zheng, Hua
Yang, Fan
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) : 9291 - 9293
[7] Management of Relapsed and Relapsed/Refractory Multiple Myeloma
Laubach, Jacob P.
Mitsiades, Constantine S.
Mahindra, Anuj
Luskin, Marlise R.
Rosenblatt, Jacalyn
Ghobrial, Irene M.
Schlossman, Robert L.
Avigan, David
Raje, Noopur
Munshi, Nikhil C.
Anderson, Kenneth C.
Richardson, Paul G.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1209 - 1216
[8] Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Gasparetto, Cristina
Lentzsch, Suzanne
Schiller, Gary
Callander, Natalie
Tuchman, Sascha
Chen, Christine
White, Darrell
Kotb, Rami
Sutherland, Heather
Sebag, Michael
Baljevic, Muhamed
Bensinger, William
Leblanc, Richard
Venner, Chris
Bahlis, Nizar
Rossi, Adriana
Biran, Noa
Sheehan, Heidi
Saint-Martin, Jean-Richard
Van Domelen, Dane
Kai, Kazuharu
Shah, Jatin
Shacham, Sharon
Kauffman, Michael
Lipe, Brea
EJHAEM, 2021, 2 (01): : 56 - 65
[9] The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma
Becnel, Melody R.
Lee, Hans C.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
[10] Bispecific Antibodies for the Management of Relapsed/Refractory Multiple Myeloma
Tacchetti, Paola
Barbato, Simona
Mancuso, Katia
Zamagni, Elena
Cavo, Michele
CANCERS, 2024, 16 (13)

← 1 2 3 4 5 →